Epidemiology of retinopathy of prematurity (ROP) in Northwest China: a decade-long retrospective single-center analysis (2015–2024) - Takeaways - MDSpire

Trends in the Epidemiology of Retinopathy of Prematurity in Northwest China: A Ten-Year Retrospective Study from a Single Center (2015–2024)

  • By

  • Jing Yang

  • Le Zhang

  • July 21, 2026

Share

  • 1

    The study analyzed retinopathy of prematurity (ROP) incidence trends at a single center in Northwest China from 2015 to 2024.

  • 2

    A total of 12,640 infants underwent 31,605 ROP screenings, with an overall incidence rate of 14.18% and a treatment-requiring rate of 1.59%.

  • 3

    ROP incidence decreased with advancing gestational age, with rates of 72.37% for GA <28 weeks and 6.17% for GA ≥32 weeks.

  • 4

    Annual screening volume, ROP incidence, and treatment demand showed fluctuating upward trends, indicating insufficient current screening practices.

  • 5

    The study suggests a risk-based screening strategy, emphasizing intensive screening for infants with GA <28 weeks.

Original Source(s)

Epidemiology of retinopathy of prematurity (ROP) in Northwest China: a decade-long retrospective single-center analysis (2015–2024)

  • by Jing Yang, Le Zhang

  • July 21, 2026

Related Content

CCL25 chemokine promotes antiviral tissue resident CD4+ and CD8+ effector memory TRM cells associated with a reduction of ocular herpes infection and disease: a potential gut–eye axis in herpes immunity

Alkeus Launches Phase 3 Stargardt Trial

At OIS Retina, Carlos Quezada Ruiz, MD, highlighted the launch of the global phase 3 NORTHSTAR trial evaluating investigational oral gildeuretinol for Stargardt disease.

Elevated GDF15 in ocular fluids of patients with proliferative diabetic retinopathy